Jc. Vis et al., 3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum, NEUROP AP N, 25(6), 1999, pp. 513-521
Systemic administration of the mitochondrial toxin 3-nitropropionic acid (3
-NP) to rats results in selective striatal lesions and serves as an experim
ental model of Huntington's disease (HD). However, the effects of the 3-NP
treatment are unpredictable and result in lesions of variable severity. The
present study was aimed at further characterizing the variability of the s
triatal lesions induced by systemic administration of 3-NP using osmotic pu
mps. Hematoxylin-eosin (HE) and Nissl stains as well as immunohistochemical
labelling of astrocytes and striatal neurones were performed to analyse th
e neurotoxic effects of 3-NP. In general, chronic systemic administration o
f 3-NP resulted in obvious bilateral striatal lesions, which ranged from mi
ld to severe, together with a subtle, but detectable behavioural lesion. Se
vere type lesions showed marked neuronal loss and an increased expression o
f glial fibrillary acidic protein (GFAP) in astrocytes surrounding the lesi
on area, whereas in the core of the lesion GFAP-immunoreactivity was absent
. The mild type lesion was characterized by a substantial loss of striatal
neurones and an increased expression of GFAP-positive astrocytes throughout
the lesion. In a number of 3-NP-treated animals, neither type of lesion wa
s observed, although these animals demonstrated behavioural changes in the
paw test compared to controls. In the striatum of these tested 3-NP-treated
animals, compromised rk' neurones were detected, suggestive of subtle and
early 3-NP-induced neuronal injury. Similar dark neurones were also detecte
d in mild and severe lesions and were immunocytochemically characterized as
gamma-aminobutyric acid (GABA) and substance P containing spiny neurones,
which belong to the neuronal population that is affected in early HD. These
results indicate that systemic administration of 3-NP to rats may result i
n a spectrum of striatal pathology of which the morphology of the mild type
lesion resembles the characteristic HD neuropathology most closely.